Secretome identification of immune cell factors mediating metastatic cell homing

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Aguado, Brian A ^a,b   Wu, Jia J ^b   Azarin, Samira M ^c   Nanavati, Dhaval ^b   Rao, Shreyas S ^d   Bushnell, Grace G ^e   Medicherla, Chaitanya B ^f   Shea, Lonnie D ^a,e  

^a Northwestern University   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c University of Minnesota   (United States)

^d University of Alabama   (United States)

^e UNIVERSITY OF MICHIGAN   (United States)

^f NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOLOGIC FACTOR;

ANIMAL; BREAST TUMOR; CELL MOTION; CELL PROLIFERATION; FEMALE; GENETICS; HUMAN; IMMUNOLOGY; METASTASIS; MOUSE; PARACRINE SIGNALING; PATHOLOGY; PROTEOMICS; SECRETION (PROCESS); SIGNAL TRANSDUCTION; SYSTEMS BIOLOGY; TUMOR INVASION;

ANIMALS; BREAST NEOPLASMS; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; MICE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PARACRINE COMMUNICATION; PROTEOMICS; SIGNAL TRANSDUCTION; SYSTEMS BIOLOGY;

EID: 84949200696     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep17566     Document Type: Article

References (50)

1. Kaplan, R. N., Rafii, S. & Lyden, D. Preparing the 'soil': The premetastatic niche. Cancer Research 66, 11089-11093 (2006).
2. Psaila, B., Kaplan, R. N., Port, E. R. & Lyden, D. Priming the 'soil' for breast cancer metastasis: the pre-metastatic niche. Breast Dis 26, 65-74 (2006).
3. Kaplan, R. N. et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438, 820-827 (2005).
4. Peinado, H., Lavotshkin, S. & Lyden, D. The secreted factors responsible for pre-metastatic niche formation: Old sayings and new thoughts. Seminars in Cancer Biology 21, 139-146 (2011).
5. Smith, H. A. & Kang, Y. The metastasis-promoting roles of tumor-associated immune cells. J Mol Med 91, 411-429 (2013).
6. DeNardo, D. G., Johansson, M. & Coussens, L. M. Immune cells as mediators of solid tumor metastasis. Cancer Metastasis Rev 27, 11-18 (2007).
7. Hiratsuka, S., Watanabe, A., Aburatani, H. & Maru, Y. Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis. Nat Cell Biol 8, 1369-1375 (2006).
8. Craig, M. J. & Loberg, R. D. CCL2 (Monocyte Chemoattractant Protein-1) in cancer bone metastases. Cancer Metastasis Rev 25, 611-619 (2006).
9. Hiratsuka, S. et al. The S100A8-serum amyloid A3-TLR4 paracrine cascade establishes a pre-metastatic phase. Nat Cell Biol 10, 1349-1355 (2008).
10. Paltridge, J. L., Belle, L. & Khew-Goodall, Y. The secretome in cancer progression. Biochim Biophys Acta 1834, 2233-2241 (2013).
11. Caccia, D., Dugo, M., Callari, M. & Bongarzone, I. Bioinformatics tools for secretome analysis. Biochim Biophys Acta 1834, 2442-2453 (2013).
12. Makridakis, M. & Vlahou, A. Secretome proteomics for discovery of cancer biomarkers. Journal of Proteomics 73, 2291-2305 (2010).
13. Boersema, P. J., Geiger, T., Wisniewski, J. R. & Mann, M. Quantification of the N-glycosylated secretome by super-SILAC during breast cancer progression and in human blood samples. Molecular & Cellular Proteomics 12, 158-171 (2012).
14. Xu, B. J. et al. Quantitative analysis of the secretome of TGF-β signaling-deficient mammary fibroblasts. Proteomics 10, 2458-2470 (2010).
15. Grimmond, S. M. et al. The mouse secretome: Functional classification of the proteins secreted into the extracellular environment. Genome Research 13, 1350-1359 (2003).
16. Siletz, A., Kniazeva, E., Jeruss, J. S. & Shea, L. D. Transcription factor networks in invasion-promoting breast carcinomaassociated fibroblasts. Cancer Microenvironment 6, 91-107 (2012).
17. Azarin, S. M. et al. In vivo capture and label-free detection of early metastatic cells. Nature Communications 6, 8094 doi: 10.1038/ncomms9094 (2015).
18. Erler, J. T. et al. Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche. Cancer Cell 15, 35-44 (2009).
19. Cox, T. R. et al. The hypoxic cancer secretome induces pre-metastatic bone lesions through lysyl oxidase. Nature 522, 106-110 (2015).
20. Flores, R. J. et al. A systems biology approach reveals common metastatic pathways in osteosarcoma. BMC Systems Biology 6, 1-17 (2012).
21. Morrison, C. et al. Microarray and proteomic analysis of breast cancer cell and osteoblast co-cultures: role of osteoblast matrix metalloproteinase (MMP)-13 in bone metastasis. Journal of Biological Chemistry 286, 34271-34285 (2011).
22. Kulasingam, V. & Diamandis, E. P. Proteomics analysis of conditioned media from three breast cancer cell lines: a mine for biomarkers and therapeutic targets. Mol. Cell Proteomics 6, 1997-2011 (2007).
23. Bussard, K. M., Venzon, D. J. & Mastro, A. M. Osteoblasts are a major source of inflammatory cytokines in the tumor microenvironment of bone metastatic breast cancer. J. Cell. Biochem. 111, 1138-1148 (2010).
24. Yang, L., Edwards, C. M. & Mundy, G. R. Gr-1 + CD11b + myeloid-derived suppressor cells: Formidable partners in tumor metastasis. J Bone Miner Res 25, 1701-1706 (2010).
25. Condeelis, J. & Pollard, J. W. Macrophages: Obligate partners for tumor cell migration, invasion, and metastasis. Cell 124, 263-266 (2006).
26. Keskinov, A. A. & Shurin, M. R. Myeloid regulatory cells in tumor spreading and metastasis. Immunobiology 220, 236-242 (2015).
27. Weiss, M. S. et al. Dynamic transcription factor activity and networks during ErbB2 breast oncogenesis and targeted therapy. Integr. Biol. 6, 1170-1182 (2014).
28. Weiss, M. S. et al. The impact of adhesion peptides within hydrogels on the phenotype and signaling of normal and cancerous mammary epithelial cells. Biomaterials 33, 3548-3559 (2012).
29. Li, Y. et al. GATA1 induces epithelial-mesenchymal transition in breast cancer cells through PAK5 oncogenic signaling. Oncotarget 6, 4345-4356 (2015).
30. Nguyen, L. K. et al. A dynamic model of the hypoxia-inducible factor 1-alpha (HIF-1a ) network. J. Cell. Sci. 126, 1454-1463 (2013).
31. Tarasewicz, E. & Jeruss, J. S. Phospho-specific Smad3 signaling: Impact on breast oncogenesis. Cell Cycle 11, 2443-2451 (2012).
32. Medjkane, S., Perez-Sanchez, C., Gaggioli, C., Sahai, E. & Treisman, R. Myocardin-related transcription factors and SRF are required for cytoskeletal dynamics and experimental metastasis. Nat Cell Biol 11, 257-268 (2009).
33. Vera, J. et al. Systems biology of JAK-STAT signaling in human malignancies. Progress in Biophysics and Molecular Biology 106, 426-434 (2011).
34. Dempsey, E. & Rudd, P. M. Acute phase glycoproteins: bystanders or participants in carcinogenesis? Annals of the New York Academy of Sciences 1253, 122-132 (2012).
35. Andersen, C. B. F. et al. Structure of the haptoglobin-haemoglobin complex. Nature 489, 456-459 (2012).
36. Tabassum, U., Reddy, O. & Mukherjee, G. Elevated serum haptoglobin is associated with clinical outcome in triple-negative breast cancer patients. Asian Pac. J. Cancer Prev. 13, 4541-4544 (2012).
37. Kumar, D. M. et al. Proteomic identification of haptoglobin a 2as a glioblastoma serum biomarker: implications in cancer cell migration and tumor growth. J. Proteome Res. 9, 5557-5567 (2010).
38. Maffei, M. et al. The obesity and inflammatory marker haptoglobin attracts monocytes via interaction with chemokine (C-C motif) receptor 2 (CCR2). BMC Biol 7, 87 (2009).
39. Fang, W. B. et al. CCL2/CCR2 chemokine signaling coordinates survival and motility of breast cancer cells through Smad3 protein-and p42/44 mitogen-activated protein kinase (MAPK)-dependent mechanisms. Journal of Biological Chemistry 287, 36593-36608 (2012).
40. Hlavaty, K. A. et al. Enhancing human islet transplantation by localized release of trophic factors from PLG scaffolds. American Journal of Transplantation 14, 1523-1532 (2014).
41. Yoneda, T., Williams, P. J., Hiraga, T., Niewolna, M. & Nishimura, R. A bone-seeking clone exhibits different biological properties from the MDA-MB-231 parental human breast cancer cells and a brain-seeking clone in vivo and in vitro. J Bone Miner Res 16, 1486-1495 (2001).
42. Liu, H., Sadygov, R. G. & Yates, J. R. A model for random sampling and estimation of relative protein abundance in shotgun proteomics. Anal. Chem. 76, 4193-4201 (2004).
43. Usaite, R. et al. Characterization of global yeast quantitative proteome data generated from the wild-type and glucose repression saccharomyces cerevisiae strains: The comparison of two quantitative methods. J. Proteome Res. 7, 266-275 (2008).
44. Zybailov, B. et al. Statistical analysis of membrane proteome expression changes in saccharomycescerevisiae. J. Proteome Res. 5, 2339-2347 (2006).
45. Vizcaino, J. A. et al. ProteomeXchange provides globally coordinated proteomics data submission and dissemination. Nature Biotechnology 32, 223-226 (2014).
46. Weiss, M. S. et al. Dynamic, large-scale profiling of transcription factor activity from live cells in 3D culture. PLoS ONE 5, e14026 (2010).
47. Siletz, A. et al. Dynamic transcription factor networks in epithelial-mesenchymal transition in breast cancer models. PLoS ONE 8, e57180 (2013).
48. Smyth, G. K., Michaud, J. & Scott, H. S. Use of within-array replicate spots for assessing differential expression in microarray experiments. Bioinformatics 21, 2067-2075 (2005).
49. Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society Series B 57, 289-300 (1995).
50. Francia, G., Cruz-Munoz, W., Man, S., Xu, P. & Kerbel, R. S. Mouse models of advanced spontaneous metastasis for experimental therapeutics. Nature Rev Cancer 11, 135-141 (2011).